These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17267121)

  • 1. Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease.
    Abahuni N; Gispert S; Bauer P; Riess O; Krüger R; Becker T; Auburger G
    Neurosci Lett; 2007 Mar; 414(2):126-9. PubMed ID: 17267121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease.
    Luoma PT; Eerola J; Ahola S; Hakonen AH; Hellström O; Kivistö KT; Tienari PJ; Suomalainen A
    Neurology; 2007 Sep; 69(11):1152-9. PubMed ID: 17846414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CARD15 variants in patients with sporadic Parkinson's disease.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Juzwiak S; Kurzawski G; Tan EK; Drozdzik M
    Neurosci Res; 2007 Mar; 57(3):473-6. PubMed ID: 17174426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of PINK1 (PARK6) polymorphisms in Finnish PD.
    Clarimón J; Eerola J; Hellström O; Peuralinna T; Tienari PJ; Singleton AB
    Neurobiol Aging; 2006 Jun; 27(6):906-7. PubMed ID: 16046032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common A340T variant in PINK1 gene associated with late-onset Parkinson's disease in Chinese.
    Wang F; Feng X; Ma J; Zou H; Chan P
    Neurosci Lett; 2006 Dec; 410(2):121-5. PubMed ID: 17084972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease.
    Behrouz B; Vilariño-Güell C; Heckman MG; Soto-Ortolaza AI; Aasly JO; Sando S; Lynch T; Craig D; Uitti RJ; Wszolek ZK; Ross OA; Farrer MJ
    Neurosci Lett; 2010 Dec; 486(3):228-30. PubMed ID: 20887776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PITX3 polymorphism is associated with early onset Parkinson's disease.
    Bergman O; Håkansson A; Westberg L; Nordenström K; Carmine Belin A; Sydow O; Olson L; Holmberg B; Eriksson E; Nissbrandt H
    Neurobiol Aging; 2010 Jan; 31(1):114-7. PubMed ID: 18420308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mutations and functions of PINK1.
    Kawajiri S; Saiki S; Sato S; Hattori N
    Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
    Sim CH; Lio DS; Mok SS; Masters CL; Hill AF; Culvenor JG; Cheng HC
    Hum Mol Genet; 2006 Nov; 15(21):3251-62. PubMed ID: 17000703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor PITX3 is associated with sporadic Parkinson's disease.
    Fuchs J; Mueller JC; Lichtner P; Schulte C; Munz M; Berg D; Wüllner U; Illig T; Sharma M; Gasser T
    Neurobiol Aging; 2009 May; 30(5):731-8. PubMed ID: 17905480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of PINK1 variants in Indian Parkinson's disease patients.
    Biswas A; Sadhukhan T; Majumder S; Misra AK; Das SK; Variation Consortium IG; Ray K; Ray J
    Parkinsonism Relat Disord; 2010 Mar; 16(3):167-71. PubMed ID: 19889566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
    Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T313M PINK1 mutation in an extended highly consanguineous Saudi family with early-onset Parkinson disease.
    Chishti MA; Bohlega S; Ahmed M; Loualich A; Carroll P; Sato C; St George-Hyslop P; Westaway D; Rogaeva E
    Arch Neurol; 2006 Oct; 63(10):1483-5. PubMed ID: 17030667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association study of PINK1 coding polymorphisms in Parkinson's disease.
    Groen JL; Kawarai T; Toulina A; Rivoiro C; Salehi-Rad S; Sato C; Morgan A; Liang Y; Postuma RB; St George-Hyslop P; Lang AE; Rogaeva E
    Neurosci Lett; 2004 Dec; 372(3):226-9. PubMed ID: 15542245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson patient fibroblasts show increased alpha-synuclein expression.
    Hoepken HH; Gispert S; Azizov M; Klinkenberg M; Ricciardi F; Kurz A; Morales-Gordo B; Bonin M; Riess O; Gasser T; Kögel D; Steinmetz H; Auburger G
    Exp Neurol; 2008 Aug; 212(2):307-13. PubMed ID: 18511044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.
    Grünewald A; Gegg ME; Taanman JW; King RH; Kock N; Klein C; Schapira AH
    Exp Neurol; 2009 Sep; 219(1):266-73. PubMed ID: 19500570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
    Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
    Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort.
    Pascale E; Passarelli E; Purcaro C; Vestri AR; Fakeri A; Guglielmi R; Passarelli F; Meco G
    Acta Neurol Scand; 2011 Sep; 124(3):176-81. PubMed ID: 20880267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the receptor for GDNF (RET) are not associated with Parkinson's disease in Southern Germany.
    Lücking CB; Lichtner P; Kramer ER; Gieger C; Illig T; Dichgans M; Berg D; Gasser T
    Neurobiol Aging; 2010 Jan; 31(1):167-8. PubMed ID: 18436345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.
    Hoepken HH; Gispert S; Morales B; Wingerter O; Del Turco D; Mülsch A; Nussbaum RL; Müller K; Dröse S; Brandt U; Deller T; Wirth B; Kudin AP; Kunz WS; Auburger G
    Neurobiol Dis; 2007 Feb; 25(2):401-11. PubMed ID: 17141510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.